Penn Scientists Use CRISPR for First Time to Correct Clotting in Newborn and Adult Mice
CRISPR/Cas9, a powerful genome editing tool, is showing promise for efficient correction of disease-causing mutations. For the first time, researchers from the Perelman School of Medicine at the University of…